These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
347 related articles for article (PubMed ID: 10380350)
1. From natural to synthetic multisite thrombin inhibitors. Lombardi A; De Simone G; Galdiero S; Staiano N; Nastri F; Pavone V Biopolymers; 1999; 51(1):19-39. PubMed ID: 10380350 [TBL] [Abstract][Full Text] [Related]
2. Hirunorms are true hirudin mimetics. The crystal structure of human alpha-thrombin-hirunorm V complex. De Simone G; Lombardi A; Galdiero S; Nastri F; Della Morte R; Staiano N; Pedone C; Bolognesi M; Pavone V Protein Sci; 1998 Feb; 7(2):243-53. PubMed ID: 9521099 [TBL] [Abstract][Full Text] [Related]
3. Design of P1' and P3' residues of trivalent thrombin inhibitors and their crystal structures. Slon-Usakiewicz JJ; Sivaraman J; Li Y; Cygler M; Konishi Y Biochemistry; 2000 Mar; 39(9):2384-91. PubMed ID: 10694407 [TBL] [Abstract][Full Text] [Related]
4. Rational design of true hirudin mimetics: synthesis and characterization of multisite-directed alpha-thrombin inhibitors. Lombardi A; Nastri F; Della Morte R; Rossi A; De Rosa A; Staiano N; Pedone C; Pavone V J Med Chem; 1996 May; 39(10):2008-17. PubMed ID: 8642559 [TBL] [Abstract][Full Text] [Related]
5. Multiple binding mode of reversible synthetic thrombin inhibitors. A comparative structural analysis. Pavone V; De Simone G; Nastri F; Galdiero S; Staiano N; Lombardi A; Pedone C Biol Chem; 1998; 379(8-9):987-1006. PubMed ID: 9792431 [TBL] [Abstract][Full Text] [Related]
7. Molecular design and characterization of an alpha-thrombin inhibitor containing a novel P1 moiety. Malikayil JA; Burkhart JP; Schreuder HA; Broersma RJ; Tardif C; Kutcher LW; Mehdi S; Schatzman GL; Neises B; Peet NP Biochemistry; 1997 Feb; 36(5):1034-40. PubMed ID: 9033393 [TBL] [Abstract][Full Text] [Related]
8. Crystal structures of thrombin complexed to a novel series of synthetic inhibitors containing a 5,5-trans-lactone template. Jhoti H; Cleasby A; Reid S; Thomas PJ; Weir M; Wonacott A Biochemistry; 1999 Jun; 38(25):7969-77. PubMed ID: 10387040 [TBL] [Abstract][Full Text] [Related]
9. Nonpolar interactions of thrombin and its inhibitors at the fibrinogen recognition exosite: thermodynamic analysis. Cheng Y; Slon-Usakiewicz JJ; Wang J; Purisima EO; Konishi Y Biochemistry; 1996 Oct; 35(40):13021-9. PubMed ID: 8855937 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and characterization of more potent analogues of hirudin fragment 1-47 containing non-natural amino acids. De Filippis V; Quarzago D; Vindigni A; Di Cera E; Fontana A Biochemistry; 1998 Sep; 37(39):13507-15. PubMed ID: 9753436 [TBL] [Abstract][Full Text] [Related]
12. Efficient synthesis of an enantiopure beta-lactam as an advanced precursor of thrombin and tryptase inhibitors. Annunziata R; Benaglia M; Cinquini M; Cozzi F; Maggioni F; Puglisi A J Org Chem; 2003 Apr; 68(7):2952-5. PubMed ID: 12662075 [TBL] [Abstract][Full Text] [Related]
13. Potent bivalent thrombin inhibitors: replacement of the scissile peptide bond at P(1)-P(1)' with arginyl ketomethylene isosteres. Steinmetzer T; Zhu BY; Konishi Y J Med Chem; 1999 Aug; 42(16):3109-15. PubMed ID: 10447955 [TBL] [Abstract][Full Text] [Related]
14. Comparison of the structures of the cyclotheonamide A complexes of human alpha-thrombin and bovine beta-trypsin. Ganesh V; Lee AY; Clardy J; Tulinsky A Protein Sci; 1996 May; 5(5):825-35. PubMed ID: 8732754 [TBL] [Abstract][Full Text] [Related]
15. Antithrombin agents as anticoagulants and antithrombotics: implications in drug development. Fareed J; Callas D; Hoppensteadt DA; Lewis BE; Bick RL; Walenga JM Semin Hematol; 1999 Jan; 36(1 Suppl 1):42-56. PubMed ID: 9930564 [TBL] [Abstract][Full Text] [Related]
16. Crystal structure of two new bifunctional nonsubstrate type thrombin inhibitors complexed with human alpha-thrombin. Féthière J; Tsuda Y; Coulombe R; Konishi Y; Cygler M Protein Sci; 1996 Jun; 5(6):1174-83. PubMed ID: 8762149 [TBL] [Abstract][Full Text] [Related]
17. Crystal structure of the complex of human alpha-thrombin and nonhydrolyzable bifunctional inhibitors, hirutonin-2 and hirutonin-6. Zdanov A; Wu S; DiMaio J; Konishi Y; Li Y; Wu X; Edwards BF; Martin PD; Cygler M Proteins; 1993 Nov; 17(3):252-65. PubMed ID: 8272424 [TBL] [Abstract][Full Text] [Related]
18. From natural products to achiral drug prototypes: potent thrombin inhibitors based on P2/P3 dihydropyrid-2-one core motifs. Hanessian S; Therrien E; Zhang J; Otterlo Wv; Xue Y; Gustafsson D; Nilsson I; Fjellström O Bioorg Med Chem Lett; 2009 Sep; 19(18):5429-32. PubMed ID: 19674897 [TBL] [Abstract][Full Text] [Related]
19. Think twice: understanding the high potency of bis(phenyl)methane inhibitors of thrombin. Baum B; Muley L; Heine A; Smolinski M; Hangauer D; Klebe G J Mol Biol; 2009 Aug; 391(3):552-64. PubMed ID: 19520086 [TBL] [Abstract][Full Text] [Related]
20. S1 subsite in snake venom thrombin-like enzymes: can S1 subsite lipophilicity be used to sort binding affinities of trypsin-like enzymes to small-molecule inhibitors? Silva FP; De-Simone SG Bioorg Med Chem; 2004 May; 12(10):2571-87. PubMed ID: 15110839 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]